Caredx to participate in upcoming investor conferences

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna), the transplant company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the company will participate in two upcoming investor conferences. caredx's management is scheduled to present at the: jefferies global healthcare conference on thursday, june 6, 2023, at.
CDNA Ratings Summary
CDNA Quant Ranking